VYOME HOLDINGS, INC. Selling and Marketing Expense
VYOME HOLDINGS, INC. (HIND) reported Selling and Marketing Expense of $583.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2025-08-14
- VYOME HOLDINGS, INC. selling and marketing expense for the quarter ending 2025-06-30 was $583.00K, a 12.99% decline year-over-year.
- VYOME HOLDINGS, INC. selling and marketing expense for the quarter ending 2025-03-31 was $529.00K, a 48.09% decline year-over-year.
- VYOME HOLDINGS, INC. selling and marketing expense for the quarter ending 2024-06-30 was $670.00K.
- VYOME HOLDINGS, INC. selling and marketing expense for the quarter ending 2024-03-31 was $1.02M.
- VYOME HOLDINGS, INC. selling and marketing expense for fiscal 2024 was $2.99M, a 60.37% decline from fiscal 2023.
- VYOME HOLDINGS, INC. selling and marketing expense for fiscal 2023 was $7.55M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 12 month |
|---|---|---|---|
| 2025-06-30 | $583.00K 10-Q · filed 2025-08-14 | $1.11M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $529.00K 10-Q · filed 2025-05-20 | ||
| 2024-12-31 | $2.99M 10-K · filed 2025-04-04 | ||
| 2024-06-30 | $670.00K 10-Q · filed 2025-08-14 | $1.69M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $1.02M 10-Q · filed 2025-05-20 | ||
| 2023-12-31 | $7.55M 10-K · filed 2025-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |